Medical Cannabis Studies

• View All (505)

Nutrition in Cancer Care (PDQ�): Health Professional Version (2017)

This report offers cancer-related information for health professionals, providing them with a comprehensive, expertly-verified, evidence-based review of nutrition before, during, and after cancer treatment. View study
On the application of cannabis in paediatrics and epileptology (2004)

A study about the therapeutic application of THC in children and adolescents with neurodegenerative diseases, epilepsy and other chronic conditions, showed that THC reduced spasticity, provoked improved dystonia, and had anticonvulsive actions. View study
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice (2011)

In this research, the aim is to evaluate the anxiolytic effects of alprazolam in different tests using mice. The results show that the increase in the expression of CB2r significantly reduced anxiety-related behaviors, modified the stress response and affected the action of anxiolytic drugs. View study
Oxycodone for neuropathic pain and fibromyalgia in adults. (2014)

This review is part of a series of medications used to treat neuropathic pain and fibromyalgia. It is estimated that these conditions affect 3 to 10% of adults and are difficult to treat. Although they probably have different etiologies, neuropathic pain and fibromyalgia can respond to the same therapies. The purpose of this research was to evaluate the analgesic efficacy and adverse events of oxycodone for chronic neuropathic pain and fibromyalgia. View study
Oxyradical Stress, Endocannabinoids, and Atherosclerosis (2015)

This research is based on the study of the possible role that endocannabinoids play in relation to the treatment of atherosclerosis and oxyradical stress. In addition to highlighting the role of reactive oxygen species (ROS) in intracellular signaling and the impact of deregulated signaling mediated by ROS in atherogenesis. View study
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis (2011)

These results demonstrate the ability and effectiveness of CBD to reduce tumor masses in animal models, highlighting its potential for the treatment of metastasis in breast cancer, and leaving the basis to develop new non-toxic compounds for these treatments. View study
Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State (2019)

Research on the patterns of use of medical cannabis among cancer patients is lacking. This research aimed to describe patterns of medicinal cannabis use in patients with cancer, and how the patterns differ from patients without cancer. View study
Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol ()

View study
Pharmacological actions and therapeutic uses of cannabis and cannabinoids (2001)

In this review, everything related to the farmcology is highlighted and its effects on anesthesia are briefly mentioned. Advances in the research of cannabinoids are also discussed and have led to the discovery of new ligands. View study
Phytocannabinoids as novel therapeutic agents in CNS disorders (2012)

This research reviews the effects of some phytocannabinoids (pCB) in preclinical models of diseases of the central nervous system (CNS). In this way diseases could be treated using (pcb) such as epilepsy, neurodegenerative diseases, affective disorders and central modulation of feeding behavior. View study
Possible endocannabinoid control of colorectal cancer growth (2003)

Endocannabinoids are produced in excess in cancerous tissue and particularly in the precancerous colon and help to inhibit the growth of colorectal cancer cells in the culture, in which the degree of action and levels appear to depend on the degree of differentiation and malignancy / invasiveness of these cells. View study
Potentiation of Cannabinoid-Induced Cytotoxicity in Mantle Cell Lymphoma through Modulation of Ceramide Metabolism (2009)

This study suggests that R (+) - methanandamide has the ability to cause cell death in mantle cell lymphoma. View study